ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1226

Studying Patients with Autoinflammatory Diseases: The Past, Present, and a Perspective for the Future

Jonathan S. Hausmann1,2, Catherine Biggs3, Donald P. Goldsmith4 and Fatma Dedeoglu1,5, 1Rheumatology, Boston Children's Hospital, Boston, MA, 2Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 3Program in Rheumatology, Divison of Immunoloty, Boston Children's Hospital, Boston, MA, 4Pediatric Rheumaology, St Christopher's Hospital for Children/ Drexel College of Medicine, Philadelphia, PA, 5on behalf of CARRAnet Investigators, Palo Alto, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Autoinflammatory Disease, Epidemiologic methods, registry and social media

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Autoinflammatory diseases (AIDs) are uncommon disorders characterized by recurrent episodes of systemic and organ-specific inflammation.  Because of their rarity, finding large numbers of patients to study has been challenging.  This project will compare the results of a retrospective chart review of patients with AIDs at a single academic medical center, with those of participants within the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, a multicenter observational pediatric rheumatic disease registry in North America.

Methods: Patients with a clinical or genetic diagnosis of AID were included in this study.  A retrospective chart review was conducted at Boston Children’s Hospital (BCH) from 2002-2012.  Charts were identified by keywords and billing codes related to AIDs and recurrent fevers.  We also conducted a cross-sectional study of children with AIDs enrolled in the CARRA registry from May 2011 to December 2013.

Results: At BCH,173 subjects with AIDs were identified.  In the CARRA registry, of 9,523 subjects enrolled, 87 patients were classified as having AIDs.  The frequency of diagnoses are found in Figure 1.

Screen Shot 2014-06-24 at 9.43.11 AM.png

Conclusion: Using the traditional methodology of a single-center retrospective chart review, we described the patients with AIDs seen at BCH, and estimated the frequency of various AIDs within this population.  This research required little cost and relatively little time.  Limitations included incomplete documentation in some cases, and the variety of AIDs identified was limited.  

The CARRA registry, on the other hand, was a modern, multicenter effort that allowed enrollment of patients from multiple sites at a faster rate, and with a greater variety of diagnoses. However, this registry required significant financial investments in technology and operational costs.  The fact that PFAPA, the most common pediatric AID, represented a minority of subjects within the CARRA registry suggests that physicians enrolled a select number of patients, possibly due to the time required for the consent, enrollment, and data-uploading processes.

Integration of registries into the patient’s electronic health records will potentially minimize the current barriers to research.  In addition, we believe that online patient communities can also contribute valuable information. In future studies, we plan to empower and engage patients with AIDs through social media to collaborate in the design and implementation of research studies. Our efforts could exponentially expand the number of patients available to participate in research, and help our understanding of these complex disorders.


Disclosure:

J. S. Hausmann,
None;

C. Biggs,
None;

D. P. Goldsmith,
None;

F. Dedeoglu,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/studying-patients-with-autoinflammatory-diseases-the-past-present-and-a-perspective-for-the-future/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology